Kostas Biliouris Score: 15
Analyst at
Oppenheimer,
BMO Capital
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
-24.6%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
27%
8 W / 22 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
33%
8 W / 16 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 24 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 24 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
22%
5 W / 18 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
27%
8 W / 22 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
0%
0 W / 0 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Jan 28, 2026 |
Entrada Therapeutics Inc
TRDA
|
BUY |
$21.00
Est. +91%
|
$11.00 | $16.45 |
Pending
|
$6.58
-40.2%
|
| Sep 05, 2025 |
Alnylam Pharmaceuticals Inc
ALNY
|
BUY |
$470.00
Est. +4%
|
$452.81 | $495.55 |
Target Met
|
$287.80
-36.4%
|
| Sep 03, 2025 |
Ionis Pharmaceuticals Inc
IONS
|
BUY |
$70.00
Est. +16%
|
$60.49 | $86.74 |
Target Met
|
$73.96
+22.3%
|
| Jul 21, 2025 |
Sarepta Therapeutics Inc
SRPT
|
BUY |
$50.00
Est. +255%
|
$14.08 | $25.32 |
Pending
|
$15.77
+12.0%
|
| Jun 24, 2025 |
Alnylam Pharmaceuticals Inc
ALNY
|
BUY |
$360.00
Est. +11%
|
$325.00 | $495.55 |
Target Met
|
$287.80
-11.4%
|
| Jun 15, 2025 |
Sarepta Therapeutics Inc
SRPT
|
BUY |
$70.00
Est. +93%
|
$36.18 | $25.32 |
Miss
|
$15.77
-56.4%
|
| Nov 05, 2024 |
Beam Therapeutics Inc
BEAM
|
BUY |
$57.00
Est. +134%
|
$24.34 | $35.25 |
Miss
|
$31.12
+27.9%
|
| Sep 19, 2024 |
4D Molecular Therapeutics Inc
FDMT
|
BUY |
$40.00
Est. +201%
|
$13.28 | $17.41 |
Miss
|
$9.22
-30.6%
|
| Sep 17, 2024 |
Biomarin Pharmaceutical Inc. - Registered Shares
BMRN
|
BUY |
$115.00
Est. +62%
|
$71.13 | $73.51 |
Miss
|
$55.65
-21.8%
|
| Sep 10, 2024 |
Centessa Pharmaceuticals plc - ADR
CNTA
|
BUY |
$20.00
Est. +25%
|
$16.02 | $22.95 |
Target Met
|
$39.76
+148.2%
|
| Aug 27, 2024 |
Alnylam Pharmaceuticals Inc
ALNY
|
BUY |
$300.00
Est. +11%
|
$269.31 | $469.81 |
Target Met
|
$287.80
+6.9%
|
| Aug 14, 2024 |
Centessa Pharmaceuticals plc - ADR
CNTA
|
BUY |
$15.00
Est. +19%
|
$12.60 | $19.08 |
Target Met
|
$39.76
+215.6%
|
| Aug 02, 2024 |
Ionis Pharmaceuticals Inc
IONS
|
BUY |
$60.00
Est. +17%
|
$51.32 | $50.37 |
Miss
|
$73.96
+44.1%
|
| Jun 27, 2024 |
Sarepta Therapeutics Inc
SRPT
|
BUY |
$200.00
Est. +29%
|
$154.79 | $155.95 |
Miss
|
$15.77
-89.8%
|
| Jun 07, 2024 |
Sarepta Therapeutics Inc
SRPT
|
BUY |
$170.00
Est. +45%
|
$117.44 | $155.95 |
Miss
|
$15.77
-86.6%
|
| Jun 05, 2024 |
BridgeBio Pharma Inc
BBIO
|
BUY |
$37.00
Est. +37%
|
$26.93 | $39.54 |
Target Met
|
$68.00
+152.5%
|
| May 17, 2024 |
Ionis Pharmaceuticals Inc
IONS
|
BUY |
$67.00
Est. +82%
|
$36.84 | $52.34 |
Miss
|
$73.96
+100.8%
|
| May 15, 2024 |
Korro Bio Inc.
KRRO
|
BUY |
$120.00
Est. +140%
|
$50.05 | $98.00 |
Miss
|
$11.61
-76.8%
|
| May 10, 2024 |
Intellia Therapeutics Inc
NTLA
|
BUY |
$70.00
Est. +182%
|
$24.84 | $28.18 |
Miss
|
$14.92
-39.9%
|
| Apr 08, 2024 |
Alnylam Pharmaceuticals Inc
ALNY
|
BUY |
$234.00
Est. +49%
|
$156.59 | $304.39 |
Target Met
|
$287.80
+83.8%
|
| Apr 03, 2024 |
Verve Therapeutics Inc
VERV
|
BUY |
$30.00
Est. +250%
|
$8.57 | $9.31 |
Miss
|
$11.13
+29.9%
|
| Mar 28, 2024 |
4D Molecular Therapeutics Inc
FDMT
|
BUY |
$63.00
Est. +99%
|
$31.59 | $28.93 |
Miss
|
$9.22
-70.8%
|
| Mar 14, 2024 |
Legend Biotech Corp - ADR
LEGN
|
BUY |
$90.00
Est. +36%
|
$66.11 | $60.87 |
Miss
|
$35.48
-46.3%
|
| Mar 13, 2024 |
Silence Therapeutics Plc - ADR
SLN
|
BUY |
$67.00
Est. +162%
|
$25.61 | $22.47 |
Miss
|
$7.00
-72.7%
|
| Feb 06, 2024 |
4D Molecular Therapeutics Inc
FDMT
|
BUY |
$70.00
Est. +128%
|
$30.71 | $28.93 |
Miss
|
$9.22
-70.0%
|
| Oct 09, 2023 |
Prime Medicine Inc
PRME
|
BUY |
$19.00
Est. +117%
|
$8.75 | $6.75 |
Miss
|
$2.78
-68.3%
|
| Jul 05, 2023 |
Biomarin Pharmaceutical Inc. - Registered Shares
BMRN
|
BUY |
$102.00
Est. +19%
|
$85.89 | $82.82 |
Miss
|
$55.65
-35.2%
|
| Dec 20, 2022 |
Beam Therapeutics Inc
BEAM
|
BUY |
$66.00
Est. +59%
|
$41.59 | - | - |
$31.12
-25.2%
|
| Jun 17, 2022 |
CRISPR Therapeutics AG
CRSP
|
BUY |
$98.00
Est. +39%
|
$70.73 | - | - |
$52.61
-25.6%
|
| Jun 16, 2022 |
Intellia Therapeutics Inc
NTLA
|
BUY |
$54.00
Est. +30%
|
$41.44 | - | - |
$14.92
-64.0%
|
Entrada Therapeutics Inc
TRDA
Jan 28, 2026
Signal & Target
BUY
$21.00
Start Price
$11.00
Best Price (1Y)
$16.45
Current Price
$6.58
Return
-40.2%
Alnylam Pharmaceuticals Inc
ALNY
Sep 05, 2025
Signal & Target
BUY
$470.00
Start Price
$452.81
Best Price (1Y)
$495.55
Current Price
$287.80
Return
-36.4%
Ionis Pharmaceuticals Inc
IONS
Sep 03, 2025
Signal & Target
BUY
$70.00
Start Price
$60.49
Best Price (1Y)
$86.74
Current Price
$73.96
Return
+22.3%
Sarepta Therapeutics Inc
SRPT
Jul 21, 2025
Signal & Target
BUY
$50.00
Start Price
$14.08
Best Price (1Y)
$25.32
Current Price
$15.77
Return
+12.0%
Alnylam Pharmaceuticals Inc
ALNY
Jun 24, 2025
Signal & Target
BUY
$360.00
Start Price
$325.00
Best Price (1Y)
$495.55
Current Price
$287.80
Return
-11.4%
Sarepta Therapeutics Inc
SRPT
Jun 15, 2025
Signal & Target
BUY
$70.00
Start Price
$36.18
Best Price (1Y)
$25.32
Current Price
$15.77
Return
-56.4%
Beam Therapeutics Inc
BEAM
Nov 05, 2024
Signal & Target
BUY
$57.00
Start Price
$24.34
Best Price (1Y)
$35.25
Current Price
$31.12
Return
+27.9%
4D Molecular Therapeutics Inc
FDMT
Sep 19, 2024
Signal & Target
BUY
$40.00
Start Price
$13.28
Best Price (1Y)
$17.41
Current Price
$9.22
Return
-30.6%
Signal & Target
BUY
$115.00
Start Price
$71.13
Best Price (1Y)
$73.51
Current Price
$55.65
Return
-21.8%
Centessa Pharmaceuticals plc - ADR
CNTA
Sep 10, 2024
Signal & Target
BUY
$20.00
Start Price
$16.02
Best Price (1Y)
$22.95
Current Price
$39.76
Return
+148.2%
Alnylam Pharmaceuticals Inc
ALNY
Aug 27, 2024
Signal & Target
BUY
$300.00
Start Price
$269.31
Best Price (1Y)
$469.81
Current Price
$287.80
Return
+6.9%
Centessa Pharmaceuticals plc - ADR
CNTA
Aug 14, 2024
Signal & Target
BUY
$15.00
Start Price
$12.60
Best Price (1Y)
$19.08
Current Price
$39.76
Return
+215.6%
Ionis Pharmaceuticals Inc
IONS
Aug 02, 2024
Signal & Target
BUY
$60.00
Start Price
$51.32
Best Price (1Y)
$50.37
Current Price
$73.96
Return
+44.1%
Sarepta Therapeutics Inc
SRPT
Jun 27, 2024
Signal & Target
BUY
$200.00
Start Price
$154.79
Best Price (1Y)
$155.95
Current Price
$15.77
Return
-89.8%
Sarepta Therapeutics Inc
SRPT
Jun 07, 2024
Signal & Target
BUY
$170.00
Start Price
$117.44
Best Price (1Y)
$155.95
Current Price
$15.77
Return
-86.6%
BridgeBio Pharma Inc
BBIO
Jun 05, 2024
Signal & Target
BUY
$37.00
Start Price
$26.93
Best Price (1Y)
$39.54
Current Price
$68.00
Return
+152.5%
Ionis Pharmaceuticals Inc
IONS
May 17, 2024
Signal & Target
BUY
$67.00
Start Price
$36.84
Best Price (1Y)
$52.34
Current Price
$73.96
Return
+100.8%
Korro Bio Inc.
KRRO
May 15, 2024
Signal & Target
BUY
$120.00
Start Price
$50.05
Best Price (1Y)
$98.00
Current Price
$11.61
Return
-76.8%
Intellia Therapeutics Inc
NTLA
May 10, 2024
Signal & Target
BUY
$70.00
Start Price
$24.84
Best Price (1Y)
$28.18
Current Price
$14.92
Return
-39.9%
Alnylam Pharmaceuticals Inc
ALNY
Apr 08, 2024
Signal & Target
BUY
$234.00
Start Price
$156.59
Best Price (1Y)
$304.39
Current Price
$287.80
Return
+83.8%
Verve Therapeutics Inc
VERV
Apr 03, 2024
Signal & Target
BUY
$30.00
Start Price
$8.57
Best Price (1Y)
$9.31
Current Price
$11.13
Return
+29.9%
4D Molecular Therapeutics Inc
FDMT
Mar 28, 2024
Signal & Target
BUY
$63.00
Start Price
$31.59
Best Price (1Y)
$28.93
Current Price
$9.22
Return
-70.8%
Legend Biotech Corp - ADR
LEGN
Mar 14, 2024
Signal & Target
BUY
$90.00
Start Price
$66.11
Best Price (1Y)
$60.87
Current Price
$35.48
Return
-46.3%
Silence Therapeutics Plc - ADR
SLN
Mar 13, 2024
Signal & Target
BUY
$67.00
Start Price
$25.61
Best Price (1Y)
$22.47
Current Price
$7.00
Return
-72.7%
4D Molecular Therapeutics Inc
FDMT
Feb 06, 2024
Signal & Target
BUY
$70.00
Start Price
$30.71
Best Price (1Y)
$28.93
Current Price
$9.22
Return
-70.0%
Prime Medicine Inc
PRME
Oct 09, 2023
Signal & Target
BUY
$19.00
Start Price
$8.75
Best Price (1Y)
$6.75
Current Price
$2.78
Return
-68.3%
Signal & Target
BUY
$102.00
Start Price
$85.89
Best Price (1Y)
$82.82
Current Price
$55.65
Return
-35.2%
Beam Therapeutics Inc
BEAM
Dec 20, 2022
Signal & Target
BUY
$66.00
Start Price
$41.59
Best Price (1Y)
-
Current Price
$31.12
Return
-25.2%
CRISPR Therapeutics AG
CRSP
Jun 17, 2022
Signal & Target
BUY
$98.00
Start Price
$70.73
Best Price (1Y)
-
Current Price
$52.61
Return
-25.6%
Intellia Therapeutics Inc
NTLA
Jun 16, 2022
Signal & Target
BUY
$54.00
Start Price
$41.44
Best Price (1Y)
-
Current Price
$14.92
Return
-64.0%